CCT2 and hepatocellular carcinoma: In conclusion, CCT2 is closely related to the development of HCC, which provides a theoretical basis for CCT2 to become a target for HCC molecular targeted therapy (Amit et al., 2010; Zou et al., 2013; Guest et al., 2015; Pavel et al., 2016; Minegishi et al., 2018).